ACA
TMDX icon

American Capital Advisory’s Transmedics TMDX Stock Holding History

American Capital Advisory’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$314 – 501
2024
Q3 		$314 Hold
2
– – ﹤0.01% 437
2024
Q2 		$158 Hold
2
– – ﹤0.01% 411
2024
Q1 		$152 Hold
2
– – ﹤0.01% 431
2023
Q4 		$158 Buy
+2
New +$121 ﹤0.01% 411

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Capital Advisory's TMDX Position: Q4 2024 in Review

American Capital Advisory sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 2 shares — an estimated $314 sold.

American Capital Advisory first reported a position in TMDX in Q4 2023 and held it in 4 quarters. The position peaked at $314 in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • American Capital Advisory reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • American Capital Advisory sold 2 Transmedics shares in Q4 2024, an estimated $314.
  • American Capital Advisory first reported a position in Transmedics in Q4 2023 and held it in 4 quarters.
  • American Capital Advisory's Transmedics position peaked at $314 in Q3 2024.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on American Capital Advisory's 13F filing for Q4 2024, filed 28 Jan 2025.